Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)
Key Information
Due Date: December 7, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Philanthropy
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant focuses on studying the ways in which cells die and respond to infection by the bacteria Mycobacterium tuberculosis, otherwise known as Mtb, and combined infection of Mtb and HIV. The goal of this grant, titled "Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection", is to encourage research that can provide valuable insight into how the human immune system interacts with these infections. The research supported by this grant can help identify potential immune system targets that can aid in the creation of therapies directly aimed at the host's body, or host-directed therapies. It is important to note that the grant will not fund clinical trials. Ultimately, the aim is to advance our understanding of these diseases and contribute towards more effective treatments.
Show More
Key Dates
Open Date: August 9, 2022
Application Due Date: December 7, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses